Papillary and follicular thyroid carcinoma
- 31 December 2000
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 14 (4), 601-613
- https://doi.org/10.1053/beem.2000.0105
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Thyrotropin Suppression and Disease Progression in Patients with Differentiated Thyroid Cancer: Results from the National Thyroid Cancer Treatment Cooperative RegistryThyroid®, 1998
- Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1998
- Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma1Journal of Clinical Endocrinology & Metabolism, 1998
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- 131I Therapy for Elevated Thyroglobulin LevelsThyroid®, 1997
- Treatment Guidelines for Patients With Thyroid Nodules and Well-Differentiated Thyroid CancerArchives of Internal Medicine, 1996
- Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodineWorld Journal of Surgery, 1994
- Influence of Diagnostic Radioiodines on the Uptake of Ablative Dose of Iodine-131Thyroid®, 1994
- Papillary and follicular thyroid cancer: Impact of treatment in 1578 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1988